Review article: Reproduction in the patient with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2007, Pages 513-533

  Heetun, Z S ^a   Byrnes, C ^a   Neary, P ^a   O'Morain, C ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; ANESTHETIC AGENT; ATROPINE PLUS DIPHENOXYLATE; AZATHIOPRINE; BETAMETHASONE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; DIAZEPAM; FOLIC ACID; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; MIDAZOLAM; PREDNISOLONE; PROPOFOL; QUINOLONE; SALAZOSULFAPYRIDINE; SCOPOLAMINE BUTYL BROMIDE; SPASMOLYTIC AGENT; STEROID; UNINDEXED DRUG;

ABDOMINAL SURGERY; ARTICLE; BEHAVIOR; BLOODY DIARRHEA; BONE MARROW TOXICITY; BREAST FEEDING; CHROMOSOME ABERRATION; CLEFT LIP; CLEFT PALATE; CONGENITAL MALFORMATION; DATA ANALYSIS; DECISION MAKING; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; ELEMENTAL DIET; EMBASE; ENTERITIS; FEMALE FERTILITY; HUMAN; INFERTILITY; INTERSTITIAL NEPHRITIS; INTESTINE OBSTRUCTION; LANGUAGE; MALE FERTILITY; MALE INFERTILITY; MEDLINE; MONOTHERAPY; MUTAGENIC ACTIVITY; NONHUMAN; OLIGOSPERMIA; PLACENTA; POPULATION RESEARCH; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REMISSION; REPRODUCTION; RISK ASSESSMENT; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TERATOGENESIS;

ADULT; AZATHIOPRINE; BREAST FEEDING; FEMALE; FERTILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REPRODUCTION; SULFASALAZINE;

EID: 34547406223     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03397.x     Document Type: Article

References (196)

1. Munkholm P. Crohn's disease - occurrence, course and prognosis. An epidemiological cohort study. Dan Med Bull 1997 44:287 302.
2. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and foetal outcome. J Clin Gastroenterol 1984 6:211 6.
3. Munkholm P. Pregnancy, fertility and disease course in patients with Crohn's Disease and ulcerative colitis. Eur J Intern Med 2000 11:215 21.
4. Moody GA, Probert C, Jayanthi V, Mayberry JF. The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire. Int J Colorectal Dis 1997 12:220 4.
5. Narendranathan M, Sandler RS, Suchindran CM, Savitz DA. Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989 11:403 6.
6. Alstead EM. Inflammatory bowel disease and pregnancy. Postgrad Med J 2002 78:23 6.
7. Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993 54:256 60.
8. Levi AJ, Fisher AM, Hughes L, Henry WF. Male infertility due to sulphasalazine. Lancet 1979 314:276 8.
9. O'Morain C, Smethurst P, Dore CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984 25:1078 84.
10. Cosentino MJ, Chey WY, Takihara H, Cockett AT. The effects of sulfasalazine on human male fertility potential and seminal prostaglandins. J Urol 1984 132:682 6.
11. Toovey S, Hudson E, Hendry WF, Levi AJ. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut 1981 22:445 51.
12. Caprilli R, Gassull MA, Escher JC, et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006 55 (Suppl. 1 i36 58.
13. Zelissen PM, van Hattum J, Poen H, Scholten P, Gerritse R, te Velde ER. Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroenterol 1988 23:1100 4.
14. Balasubramanian K, Aruldhas MM, Govindarajulu P. Effect of corticosterone on rat epididymal lipids. J Androl 1987 8:69 73.
15. Lerman SA, Miller GK, Bohlman K, et al. Effects of corticosterone on reproduction in male Sprague-Dawley rats. Reprod Toxicol 1997 11:799 805.
16. Roberts AC, McClure RD, Weiner RI, Brooks GA. Overtraining affects male reproductive status. Fertil Steril 1993 60:686 92.
17. Ligumsky M, Badaan S, Lewis H, Meirow D. Effects of 6-mercaptopurine treatment on sperm production and reproductive performance: a study in male mice. Scand J Gastroenterol 2005 40:444 9.
18. Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000 95:684 8.
19. Kane SV. What's good for the goose should be good for the gander - 6-MP use in fathers with inflammatory bowel disease. Am J Gastroenterol 2000 95:581.
20. Dejaco C, Mittermaier C, Reinisch W, et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001 121:1048 53.
21. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003 124:9 17.
22. Golby M. Fertility after renal transplantation. Transplantation 1970 10:201 7.
23. Caprilli R, Angelucci E, Cocco A, et al. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig Liver Dis 2005 37:407 17.
24. Hinkes E, Plotkin D. Reversible drug-induced sterility in a patient with acute leukemia. JAMA 1973 223:1490 1.
25. Sussman A, Leonard JM. Psoriasis, methotrexate, and oligospermia. Arch Dermatol 1980 116:215 7.
26. Kim MM, Lee SH, Lee MG, Hwang SJ, Kim CK. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats. Biopharm Drug Dispos 1995 16:279 93.
27. Rutgeerts P, Van Assche G, Vermeire S. Review article: infliximab therapy for inflammatory bowel disease - seven years on. Aliment Pharmacol Ther 2006 23:451 64.
28. D'haens G. Infliximab for ulcerative colitis: finally some answers. Gastroenterology 2005 128:2161 4.
29. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005 353:2462 76.
30. Treacy G. Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNF-α monoclonal antibody. Hum Exp Toxicol 2000 19:226 8.
31. Hanauer S, Luká M, MacIntosh D, Rutgeerts P, Sandborn W, Pollack P. A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease. Gastroenterology 2004 127:332.
32. Hueting WE, Gooszen HG, van Laarhoven CJ. Sexual function and continence after ileo pouch anal anastomosis: a comparison between a meta-analysis and a questionnaire survey. Int J Colorectal Dis 2004 19:215 8.
33. Berndtsson I, Oresland T, Hulten L. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study. Scand J Gastroenterol 2004 39:374 9.
34. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980 21:469 74.
35. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 1984 25:52 6.
36. Fielding JF, Cooke WT. Pregnancy and Crohn's disease. BMJ 1970 2:76 7.
37. De Dombal FT, Watts JM, Watkinson G, Goligher JC. Ulcerative colitis and pregnancy. Lancet 1965 25:599 602.
38. Elbaz G, Fich A, Levy A, Holcberg G, Sheiner E. Inflammatory bowel disease and preterm delivery. Int J Gynaecol Obstet 2005 90:193 7.
39. Sheiner E, Shoham-Vardi I, Hershkovitz R, Katz M, Mazor M. Infertility treatment is an independent risk factor for cesarean section among nulliparous women aged 40 and above. Am J Obstet Gynecol 2001 185:888 92.
40. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990 99:987 94.
41. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997 58:229 37.
42. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986 27:821 5.
43. Arkuran C, McComb P. Crohn's disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol 2000 27:12 3.
44. Penn I, Makowski E, Droegemueller W, Halgrimson CG, Starzl TE. Parenthood in renal homograft recipients. JAMA 1971 216:1755 61.
45. Gillibrand PN. Systemic lupus erythematosus in pregnancy treated with azathioprine. Proc R Soc Med 1966 59:834.
46. Darai E, Marpeau O, Thomassin I, Dubernard G, Barranger E, Bazot M. Fertility after laparoscopic colorectal resection for endometriosis: preliminary results. Fertil Steril 2005 84:945 50.
47. Mohr C, Nezhat FR, Nezhat CH, Seidman DS, Nezhat CR. Fertility considerations in laparoscopic treatment of infiltrative bowel endometriosis. JSLS 2005 9:16 24.
48. Coronado C, Franklin RR, Lotze EC, Bailey HR, Valdes CT. Surgical treatment of symptomatic colorectal endometriosis. Fertil Steril 1990 53:411 6.
49. Ording Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002 122:15 9.
50. Olsen KO, Joelsson M, Laurberg S, Oresland T. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 1999 86:493 5.
51. Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004 47:1119 26.
52. Calderwood AH, Kane SV. IBD and pregnancy. MedGenMed 2004 6:14.
53. Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod 2005 34:581 8.
54. Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynaecol Obstet 2004 270:79 85.
55. Miller JP. Inflammatory disease in pregnancy: a review. J R Soc Med 1986 79:221 5.
56. Asimakopoulos G. Pregnancy and inflammatory bowel disease. Rev Med Chir Soc Med Nat Iasl 2004 108:46 50.
57. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Foetal Neonatal Med 2004 15:237 41.
58. Woolfson K, Cohen Z, McLeod RS. Crohn's disease and pregnancy. Dis Colon Rectum 1990 33:869 73.
59. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - A population-based cohort study. Am J Obstet Gynecol 1997 177:942 6.
60. Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000 95:3165 70.
61. Lamah M, Scott HJ. Inflammatory bowel disease and pregnancy. Int J Colorectal Dis 2002 17:216 22.
62. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002 97:641 8.
63. Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984 19:724 32.
64. Lene Riis, Ida Vind, Patrizia Politi, et al. On behalf of the European Collaborative study group on inflammatory bowel disease (EC-IBD). Does pregnancy change the disease course? A Study in a European Cohort of Patients with Inflammatory Bowel Disease. Am J Gastroenterol 2006 101:1539 45.
65. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998 93:2426 30.
66. Schofield PF, Turnbull RB, Hawk WA. Crohn's disease and pregnancy. BMJ 1970 1:364.
67. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy and birth weight. Am J Gastroenterol 2000 95:1021 6.
68. Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2005 11:42 7.
69. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol 1996 20:115 26.
70. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996 110:424 31.
71. Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005 100:102 5.
72. Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983 18:735 42.
73. Mogadam M, Korelitz BI, Ahmed SW, Dobbins WO, 3rd., Baiocco PJ. The course of inflammatory bowel disease during pregnancy and post partum. Am J Gastroenterol 1981a 75:265 9.
74. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998 27:213 24.
75. Abramson D, Jankelson IR, Milner LR. Pregnancy in idiopathic ulcerative colitis. Am J Obstet Gynecol 1951 61:121 9.
76. Ravid A, Richard CS, Spencer LM, et al. Pregnancy, delivery and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2002 45:1283 8.
77. Juhasz ES, Fozard B, Dozois RR, Ilstrup DM, Nelson H. Ileal pouch-anal anastomosis function following childbirth: an extended evaluation. Dis Colon Rectum 1995 38:159 65.
78. Ilnyckyji A, Blanchard JF, Rawsthorne P, Bernstein CN. Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol 1999 94:3274 8.
79. Sultan AH, Kamm MA, Hudson CN, Thomas JM, Bartram CI. Anal-sphincter disruption during vaginal delivery. N Engl J Med 1993 329:1905 11.
80. Kitayama T, Funayama Y, Fukushima K, et al. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg Today 2005 35:211 5.
81. Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005 48:1691 9.
82. Hahnloser D, Pemberton JH, Wolff BG, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum 2004 47:1127 35.
83. Homan WP, Thorbjarnarson B. Crohn disease and pregnancy. Arch Surg 1976 111:545 7.
84. De Dombal FT, Burton IL, Goligher JC. Crohn's disease and pregnancy. BMJ 1972 3:550 3.
85. Katz JA. Pregnancy and inflammatory bowel disease. Curr Opin Gastroenterol 2004 20:328 32.
86. Brandt LJ, Estabrook SG, Reinus JF. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease. Am J Gastroenterol 1995 90:1918 22.
87. Rogers RG, Katz VL. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol 1995 12:262 4.
88. Weterman IT. Fertility and pregnancy in inflammatory bowel disease. Neth J Med 1989 35 (Suppl. 1 S67 75.
89. Restellini A. Inflammatory diseases of the digestive system and pregnancy: clinical case and review of the literature. Schweiz Rundsch Med Prax 1989 78:560 4.
90. Castiglione F, Pignata S, Morace F, et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996 28:199 204.
91. Nwokolo CU, Tan WC, Andrews HA, Allan RN. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut 1994 35:220 3.
92. Subhani JM, Hamiliton MI. Review article: the management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 1998 12:1039 54.
93. Cappell MS, Colon VJ, Sidhom OA. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 1996 41:2353 61.
94. Katz JA. Endoscopy in the pregnancy patient with inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002 12:636 46.
95. Mahadevan U, Kane S. American Gastroenterological Association Institute Technical Review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006 131:283 311.
96. Celleno D, Capogna G, Tomassetti M, Costantino P, Di Feo G, Nisini R. Neurobehavioural effects of propofol on the neonate following elective caesarean section. Br J Anaesth 1989 62:649 54.
97. Yau G, Gin T, Ewart MC, Kotur CF, Leung RK, Oh TE. Propofol for induction and maintenance of anaesthesia at caesarean section. A comparison with thioprentone/enflurane. Anaesthesia 1991 46:20 3.
98. Abboud TK, Zhu J, Richardson M, Peres Da Silva E, Donovan M. Intravenous propofol vs thiamylai-isoflurane for caesarean section, comparative maternal and neonatal effects. Acta Anaesthesiol Scand 1995 39:205 9.
99. Gregory MA, Gin T, Yau G, Leung RK, Chan K, Oh TE. Propofol infusion anaesthesia for caesarean section. Can J Anaesth 1990 37:514 20.
100. Valtonen M, Kanto J, Rosenbery P. Comparison of propofol and thiopentone for induction of anesthesia for elective caesarean section. Anaesthesia 1989 44:758 62.
101. Gint T, Gregory MA, Oh TE. The haemodynamic effects of propofol and thiopentone for induction anaesthesia for caesarean section. Anaesth Intensive Care 1990 18:175 9.
102. Connell W, Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 1999 21:311 23.
103. O'Morain CA. Does nutritional therapy in inflammatory bowel disease have a primary or an adjunctive role? Scand J Gastroenterol Suppl 1990 172:29 34.
104. O'Sullivan M, O'Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2006 20:561 73.
105. Teahon K, Pearson M, Levi AJ, Bjarnason I. Elemental diet in the management of Crohn's disease during pregnancy. Gut 1991 32:1079 81.
106. Jarnerot G, Into-Malmberg MB, Esbjorner E. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol 1981a 16:693 7.
107. Gionchetti P, Campieri M, Belluzzi A, et al. Bioavailability of single and multiple doses of a new oral formulation of 5-ASA in patients with inflammatory bowel disease and healthy volunteers. Aliment Pharmacol Ther 1994 8:535 40.
108. Jarnerot G, Andersen S, Esbjorner E, Sandstrom B, Brodersen R. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol 1981b 16:1049 55.
109. Esbjorner E, Jarnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand 1987 76:137 42.
110. Moskovitz DN, Bodian C, Chapman ML, et al. The effect on the foetus of medications used in pregnant inflammatory bowel disease patients. Am J Gastroenterol 2004 99:656 61.
111. Mogadam M, Dobbins WO, 3rd., Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981b 80:72 6.
112. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996 53:645 51.
113. Jansen G, Van der Heijden J, Oerlemans R, et al. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. Arthritis Rheum 2004 50:2130 9.
114. Norgard B, Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001 15:483 6.
115. Marteau P, Tennenbaum R, Elefant E, Lemann M, Cosnes J. Foetal outcome in women with IBD treated during pregnancy with oral mesalazine microgranules. Alim Pharmacol Ther 1998 12:1101 8.
116. Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998 114:23 8.
117. Colombel JF, Brabant G, Gubler MC, et al. Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet 1994 344:620 1.
118. Marteau P, Seksik P, Beaugerie L, et al. Recommendations for clinical practice for the treatment of ulcerative colitis. Gastroenterol Clin Biol 2004 28 (10 Pt. 2):955 60.
119. Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998 58:2 5.
120. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999 86:242 4.
121. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000 62:385 92.
122. Reinisch JM, Simon NG, Karow WG, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978 202:436 8.
123. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004 18:93 101.
124. Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled budesonide. Curr Med Res Opin 2005 21:1075 84.
125. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review. Hum Exp Toxicol 2006 25:447 52.
126. Kihlstrom I, Lundberg C. Teratogenicity study of the new glucocorticoid budesonide in rabbits. Arzneimittelforschung 1987 37:43 6.
127. Padbury JF, Ervin MG, Polk DH. Extrapulmonary effects of antenatally administered steroids. J Pediatr 1996 128:167 72.
128. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res 1973 7:509 19.
129. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977 127:264 7.
130. Petersen MC, Nation RL, Ashley JJ, McBride WG. The placental transfer of betamethasone. Eur J Clin Pharmacol 1980 18:245 7.
131. Dancis J, Jansen V, Levitz M. Placental transfer of steroids: effect of binding to serum albumin and to placenta. Am J Physiol 1980 238:E208 13.
132. Polifka JE, Friedman JM. Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002 65:240 61.
133. de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 2006 101:1390 2.
134. de Boer NK, Van Elburg RM, Wilhelm AJ, et al. 6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child. Scand J Gastroenterol 2005 40:1374 7.
135. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000 160:610 9.
136. Norgard B, Pedersen L, Fonager K, Rasmussen SN, Sorensen HT. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 2003 17:827 34.
137. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990 99:443 6.
138. Oefferlbauer-Ernst A, Reinisch W, Miehsler W, Vogelsang H, Dejaco C. Healthy offspring in parents both receiving thiopurines. Gastroenterology 2004 126:628.
139. DeWitte DB, Buick MK, Cyran SE, Maisels MJ. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 1984 105:625 8.
140. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynecol 1985 92:233 9.
141. Milunsky A, Graef JW, Gaynor MF Jr. Methotrexate-induced congenital malformations. J Pediatr 1968 72:790 5.
142. Bawle EV, Conard JV, Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology 1998 57:51 5.
143. Lipscomb GH, Givens VM, Meyer NL, Bran D. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol 2005 192:1844 7.
144. Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 1994 49:79 81.
145. Albengres E, Le Louet H, Tillement JP. Immunosuppressive drugs and pregnancy: experimental and clinical data. Transplant Proc 1997 29:2461 6.
146. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001 71:1051 5.
147. Anderson JB, Turner GM, Williamson RC. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med 1987 80:492 4.
148. Jayaprakash A, Gould S, Lim AG, Shehata HA. Use of cyclosporin in pregnancy. Gut 2004 53:1386 7.
149. Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy. Gut 2006 55:1364 5.
150. Dor R, Blanshard C. Caution with the use of cyclosporin in pregnancy. Gut 2003 52:1070.
151. Jain A, Venkataramanan R, Fung JJ, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997 64:559 65.
152. Jain AB, Reyes J, Marcos A, et al. Pregnancy after liver transplantation with tacrolimus immunosppression: a single center's experience update at 13 years. Transplantation 2003 76:827 32.
153. Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000 70:1718 21.
154. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study. Eur J Obstet Gynecol Reprod Biol 2001 97:188 92.
155. Berkovitch M, Diav-Citrin O, Greenberg R, et al. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol 2004 58:298 302.
156. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995 1(2 Pt 1):525 9.
157. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis Br J Clin Pharmacol 1997 44:179 82.
158. Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993 82:348 52.
159. Sorensen HT, Larsen H, Jensen ES, et al. Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J Antimicrob Chemother 1999 44:854 6.
160. Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 2001 63:186 92.
161. Linseman DA, Hampton LA, Branstetter DG. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 1995 28:59 64.
162. Loebstein R, Addis A, Ho E, et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998 42:1336 9.
163. Larsen H, Nielsen GL, Schonheyder HC, Olesen C, Sorensen HT. Birth outcome following maternal use of fluoroquinolones. Int J Antimicrob Agents 2001 18:259 62.
164. Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994 84:535 8.
165. Einarson A, Mastroiacovo P, Arnon J, et al. Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol 2000 14:185 7.
166. Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician 2003 67:2517 24.
167. Collins E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981 5 (Suppl. 57S 62S.
168. Khanna D, McMahon M, Furst DE. Safety of tumour necrosis factor-alpha antagonists. Drug Saf 2004 27:307 24.
169. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003 21:3365 9.
170. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of Pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004 99:2385 92.
171. Lichtenstein G, Cohen RD, Feagan BG, et al. Safety of infliximab in Crohn's disease: data from the 5000-patient TREAT Registry (abstr). Gastroenterology 2004 126:A54.
172. Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005 21:733 8.
173. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 2005 54:890.
174. Bergstrand O, Hellers G. Breast-feeding during infancy in patients who later develop Crohn's disease. Scand J Gastroenterol 1983 18:903 6.
175. Branski D, Kerem E, Gross-Kieselstein E, Hurvitz H, Litt R, Abrahamov A. Bloody diarrhea - a possible complication of sulfasalazine transferred through human breast milk. J Pediatr Gastroenterol Nutr 1986 5:316 7.
176. Nelis G. Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet 1989 i:383.
177. Silverman DA, Ford J, Shaw I, Probert CS. Is mesalazine really safe for use in breastfeeding mothers? Gut 2005 54:170 1.
178. Christensen LA. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man. Dan Med Bull 2000 47:20 41.
179. Jusko WJ. Pharmacokinetics and receptor-mediated pharmacodynamics of corticosteroids. Toxicology 1995 102:189 96.
180. Committee on Drugs American Academy of Pediatrics. Transfer of drugs and other chemicals into human milk. Pediatrics 2001 108:776 9.
181. Matheson I, Lunde PK, Bredesen JE. Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol 1990 30:787 93.
182. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991 324:84 8.
183. Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998 16:351 5.
184. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996 111:597 603.
185. Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A. Siblings and the riks of inflammatory bowel disease. Scand J Gastroenterol 2002 37:1301 8.
186. Odes S. Changing epidemiology of ulcerative colitis and Crohn's disease in Jews and Arabs in southern Israel. Gut 2003 52 (Suppl. VI A39.
187. Russell RK, Farhadi R, Wilson M, Drummond H, Satsangi J, Wilson DC. Parental smoking during pregnancy and an atopic background predispose to paediatric inflammatory bowel disease. Gut 2005 54 (Suppl. II A2.
188. Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke - a case-control study. Gut 1990 31:1377 81.
189. Sandler RS, Sandler DP, McDonnell CW, Wurzelmann JI. Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidem 1992 135:603 8.
190. Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol 2004 18:525 39.
191. Faybush EM, Blanchard JF, Rawsthorne P, Bernstein CN. Generational differences in the age at diagnosis with IBD: genetic anticipation, bias or temporal effects. Am J Gastroenterol 2002 97:636 40.
192. Flampe J, Heyman K, Kruis W, Raedler A, Folsch UR, Schreiber S. Anticipation in inflammatory bowel disease: a phenomenon caused by accumulation of confounders. Am J Med Genet 2000 92:178 83.
193. Lee JC, Bridger S, Mc Gregor C, Macpherson AH, James JE. Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parents. Gut 1999 44:808 11.
194. Van Ranst M, Joossens M, Joossens S, et al. Crohn's disease and month of birth. Inflamm Bowel Dis 2005 11:597 9.
195. Pardi DS, Tremaine WJ, Sandborn WJ, Loftus EV Jr., Poland GA, Melton LJ, 3rd. Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease. Inflamm Bowel Dis 1999 5:104 6.
196. Administration FDA. Regulations 1980 44:37434 67.